|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.820 CNY | -0.20% |
|
-1.60% | -14.98% |
| 06-02 | Joincare Pharmaceutical Gets China Regulatory Acceptance for Ankylosing Spondylitis Drug Application | MT |
| 06-02 | Joincare Pharmaceutical Extends Employee Stock Ownership Plan | MT |
| Market Cap | 17.53B 2.59B 2.24B 2.07B 1.94B 3.62B 248B 3.7B 24.68B 9.56B 119B 9.71B 9.5B 415B | P/E Ratio 2026 * |
12.3x | P/E Ratio 2027 * | 11.3x |
|---|---|---|---|---|---|
| Enterprise Value | 17.53B 2.59B 2.24B 2.07B 1.94B 3.62B 248B 3.7B 24.68B 9.56B 119B 9.71B 9.5B 415B | EV / Sales 2026 * |
1.08x | EV / Sales 2027 * | 1.01x |
| Free-Float |
47.5% | Yield 2026 * |
2.24% | Yield 2027 * | 2.34% |
| 1 day | -0.20% | ||
| 1 week | -1.60% | ||
| Current month | -3.73% | ||
| 1 month | -8.74% | ||
| 3 months | -13.10% | ||
| 6 months | -20.49% | ||
| Current year | -14.98% |
| 1 week | 9.56 |  | 9.95 |
| 1 month | 9.56 | | 11.13 |
| Current year | 9.56 | | 12.41 |
| 1 year | 9.56 | | 14.21 |
| 3 years | 9.4 | | 14.21 |
| 5 years | 9.4 | | 15.03 |
| 10 years | 6.28 | | 22.47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nan Qi Lin
PSD | President | 44 | 27/08/2024 |
Qing Feng Qiu
DFI | Director of Finance/CFO | 55 | 23/11/2020 |
Zhi Wei Xing
PRN | Corporate Officer/Principal | 40 | 26/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bao Guo Zhu
CHM | Chairman | 64 | 01/01/2002 |
Qing Feng Qiu
CHM | Chairman | 55 | 01/06/2005 |
Guang Xia Liu
BRD | Director/Board Member | 57 | 09/05/2001 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/02/25 | Sell | 2,000 | 0.0001% | |||
| 26/12/23 | Buy | Chief Executive Officer | 60,000 | 0.0031% | ||
| 19/12/22 | Buy | Executive/Senior Manager | 180,000 | 0.0093% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.20% | -1.60% | -17.76% | -26.22% | 2.59B | |
| +2.66% | +3.10% | +43.48% | +160.53% | 1,013B | |
| +0.36% | +4.77% | +53.97% | +49.50% | 574B | |
| +0.57% | +0.32% | +17.84% | +63.85% | 397B | |
| -0.37% | +4.97% | +21.24% | +15.95% | 324B | |
| +0.85% | +0.18% | +24.50% | +14.78% | 280B | |
| +2.10% | +4.92% | +25.30% | +33.80% | 273B | |
| +5.02% | +2.40% | +21.27% | +62.81% | 182B | |
| -0.19% | -0.46% | -45.32% | -48.35% | 194B | |
| +4.44% | -1.78% | +16.08% | +62.95% | 151B | |
| Average | +1.53% | +2.29% | +16.06% | +38.96% | 339.12B | |
| Weighted average by Cap. | +1.60% | +3.99% | +29.56% | +72.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.16B 2.39B 2.07B 1.91B 1.79B 3.34B 228B 3.41B 22.76B 8.81B 110B 8.95B 8.76B 383B | 17.42B 2.57B 2.23B 2.06B 1.93B 3.6B 246B 3.67B 24.53B 9.5B 119B 9.65B 9.44B 412B |
| Net income | 1.46B 215M 187M 172M 161M 302M 20.62B 308M 2.05B 796M 9.94B 808M 791M 34.56B | 1.59B 235M 204M 188M 176M 329M 22.47B 335M 2.24B 867M 10.83B 881M 862M 37.66B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/06/26 | 9.820 ¥ | -0.20% | 10,440,970 |
| 10/06/26 | 9.840 ¥ | +1.23% | 11,686,620 |
| 09/06/26 | 9.720 ¥ | +0.73% | 11,018,673 |
| 08/06/26 | 9.650 ¥ | -2.62% | 13,837,264 |
| 05/06/26 | 9.910 ¥ | +1.12% | 10,004,650 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600380 Stock
Select your edition
All financial news and data tailored to specific country editions
